Contact Us

Home Therapeutic Areas Rare Diseases

Therapeutic Areas

Rare Diseases

Specialised therapies for rare conditions, improving access to treatments that are often difficult to obtain.
Our Portfolio

Products in this therapeutic area

2 products manufactured or supplied by Sudair Pharma. Product information is intended for healthcare professionals; please refer to the approved prescribing information.

Pulmonary Hypertension

Redunix

Redunix® Indication: Treatment of idiopathic or heritable pulmonary arterial hypertension (PAH) in patients with moderate symptoms. Strengths: 2.5 mg/ml, 5 mg/ml Dosage Form: Solution for Infusion Active Ingredient: Treprostinil Sodium

Maacy

Maacy® Indication: Treatment of pulmonary arterial hypertension (PAH) in adults. Strength: 10 mg Dosage Form: Film-Coated Tablets Active Ingredient: Macitentan

Manufactured to international standards

Every product in this portfolio is made under cGMP, in facilities aligned to SFDA, PIC/S, ISO and WHO expectations.
Enquiries

Looking for product information?

Our medical and regulatory teams can support healthcare professionals with product enquiries and prescribing information.
Contact us
Pharmacovigilance